Join SLB | Contact Us | Members Only
Email: firstname.lastname@example.org to submit an article for the next issue!
SLB offering student and postdoc travel award to Phagocyte GRS
Posted: 4/23/2015 -
Phagocyte GRS Travel Awards from SLB
April 2015 iSLB now online!
View the latest issue of iSLB available online. This issue features the 2015 Bonazinga winner, an introduction of a new SLB work group, a W&D interview with long time SLB member, Rachel Caspi, and much more.
Message from the JLB Editor
Dear SLB Members and Supporters,
I am reaching out to you to share our excitement for JLB and to ask that you keep JLB at the forefront for your manuscript submissions in 2015. JLB has become a preferred journal in which to publish, featuring outstanding editorials, reviews and articles on high quality science. I trust that after you read this brief letter you will continue to support JLB through manuscript submissions and citations, and thereby insure the journal’s continued move upward in quality and recognition.
JLB science impact goes well beyond its readers. It is essential to have a robust and vibrant journal with a large number of excellent papers reflecting the diversity of SLB and extending into new scientific areas. In addition to serving as the main medium for disseminating the science of the Society, JLB also serves an important role for SLB through revenue generation. 100% of journal proceeds go directly to support:
• Peer community building & networking (yearly SLB meetings)
• Junior investigator professional development training
• Women and diversity initiatives for junior/established faculty
• Graduate student meeting scholarships
• Member Journal Clubs
• General SLB operations
• JLB improvement (i.e., our new journal format and website, etc.)
We are the ones that determine JLB’s impact factor. Publishing in JLB benefits us as a scientific community: not shareholders, as is the case for many commercial journals our members may submit their best science to. I know the pressure to publish by impact factor alone is intense, yet the irony is that WE can decide where our best science goes and what science we cite each time we draft a paper, and this drives impact factor! So we do have a direct hand in determining which journals will remain in the higher- or lower-tier, respectively. Importantly, JLB has maintained its impact whereas many journals have dropped as the on-line journal landscape has grown. The reason JLB has remained strong is that:
• JLB is a brand name that stands for excellence and a well-known community of peers
• JLB has no submission fee and no color charges
• Reviews completed within <23 days
• Reviewers/editors maintain high standards for content
• Our science gets cited in new manuscripts being drafted
We need you to act for JLB to excel. I am asking you directly to consider all factors when drafting your next manuscript and deciding where to submit it, including:
• How your manuscript will define the future impact factor of where you submit.
• Who ultimately will benefit from the revenue generated from your next high impact science
• Actively citing journals you support when relevant to the introduction or discussion of a new manuscript, thereby contributing to the impact factor of those journals.
We are excited by the tremendous progress JLB has achieved in the last 5 years. Now for the first time, I am calling on our membership and supporters to take pride in our progress and take an active role in building a stronger JLB beyond 2015. We are fortunate that we have a journal that is entirely run by, serves and supports our community.
Thank you for your support if you already publish with us. I look forward to our greater future "investment" into a stronger JLB this year and in the years to come. In the end, it is up to us.
Looking forward to 2015!
Luis J. Montaner, D.V.M., M.Sc., D.Phil.
Editor-In-Chief, Journal Leukocyte Biology
Kean Family Endowed Professor, The Wistar Institute
SLB and Neutro2016 announce 2016 International Conference
Posted: 1/22/2015 -
SLB Symposium at IMMUNOLOGY 2015
First European Chemokine and Cell Migration Conference (ECMC)
International Eosinophil Society 9th Biennial Symposium
9650 Rockville Pike - Bethesda, MD 20814 - P: 301-634-7814 - F: 301-634-7455 - email@example.com
Copyright © 2015 by the Society for Leukocyte Biology.